Literature DB >> 13129596

Trial of intraventricular ribavirin therapy for subacute sclerosing panencephalitis in Japan.

Akemi Tomoda1, Keiko Nomura, Seiji Shiraishi, Akinobu Hamada, Takafumi Ohmura, Mitsuaki Hosoya, Teruhisa Miike, Yukio Sawaishi, Hiroshi Kimura, Hiroshi Takashima, Yoshihiro Tohda, Kenji Mori, Zenichiro Kato, Ai Fukushima, Hisanori Nishio, Akio Nezu, Kenji Nihei.   

Abstract

Ten patients with SSPE were surveyed during the last 4 years from the viewpoint of clinical safety for use of ribavirin therapy. Although effectiveness varied among cases, they were all treated safely with intraventricular ribavirin. This study suggests that treatment is safe and well-tolerated.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 13129596     DOI： 10.1016/s0387-7604(03)00062-7

Source DB:  PubMed          Journal:  Brain Dev        ISSN： 0387-7604            Impact factor:   1.961


  10 in total

1.  Pharmacokinetics and effects of ribavirin following intraventricular administration for treatment of subacute sclerosing panencephalitis.

Authors:  Mitsuaki Hosoya; Shuichi Mori; Akemi Tomoda; Kenji Mori; Yukio Sawaishi; Hiroshi Kimura; Shiro Shigeta; Hitoshi Suzuki
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

2.  Subacute Sclerosing Panencephalitis in Children: The Archetype of Non-Vaccination.

Authors:  Laura Papetti; Maria Elisa Amodeo; Letizia Sabatini; Melissa Baggieri; Alessandro Capuano; Federica Graziola; Antonella Marchi; Paola Bucci; Emilio D'Ugo; Maedeh Kojouri; Silvia Gioacchini; Carlo Efisio Marras; Carlotta Ginevra Nucci; Fabiana Ursitti; Giorgia Sforza; Michela Ada Noris Ferilli; Gabriele Monte; Romina Moavero; Federico Vigevano; Massimiliano Valeriani; Fabio Magurano
Journal:  Viruses       Date:  2022-03-31       Impact factor: 5.818

Review 3.  Subacute sclerosing panencephalitis.

Authors:  Ravindra Kumar Garg
Journal:  J Neurol       Date:  2008-10-14       Impact factor: 4.849

4.  Acute mumps cerebellitis with abnormal findings in MRI diffusion-weighted images.

Authors:  Eiji Matsukuma; Zenichiro Kato; Koji Orii; Takahiko Asano; Kenji Orii; Eiko Matsui; Hideo Kaneko; Naomi Kondo
Journal:  Eur J Pediatr       Date:  2007-08-10       Impact factor: 3.183

Review 5.  Subacute sclerosing panencephalitis: results of the Canadian Paediatric Surveillance Program and review of the literature.

Authors:  Craig Campbell; Simon Levin; Peter Humphreys; Wikke Walop; Renee Brannan
Journal:  BMC Pediatr       Date:  2005-12-15       Impact factor: 2.125

Review 6.  Subacute sclerosing panencephalitis - current perspectives.

Authors:  Sidra K Jafri; Raman Kumar; Shahnaz H Ibrahim
Journal:  Pediatric Health Med Ther       Date:  2018-06-26

Review 7.  Measles Encephalitis: Towards New Therapeutics.

Authors:  Marion Ferren; Branka Horvat; Cyrille Mathieu
Journal:  Viruses       Date:  2019-11-02       Impact factor: 5.048

Review 8.  Advances in Antiviral Therapy for Subacute Sclerosing Panencephalitis.

Authors:  Koichi Hashimoto; Mitsuaki Hosoya
Journal:  Molecules       Date:  2021-01-15       Impact factor: 4.411

Review 9.  A Comprehensive Investigation of the Current Subacute Sclerosing Panencephalitis (SSPE) Treatment Options to Improve Patient Quality of Life.

Authors:  Ariana Pritha; Tanisha N Medha; Ravindra K Garg
Journal:  Cureus       Date:  2022-08-25

10.  In vivo nose-to-brain delivery of the hydrophilic antiviral ribavirin by microparticle agglomerates.

Authors:  Alessandro Giuliani; Anna Giulia Balducci; Elisa Zironi; Gaia Colombo; Fabrizio Bortolotti; Luca Lorenzini; Viola Galligioni; Giampiero Pagliuca; Alessandra Scagliarini; Laura Calzà; Fabio Sonvico
Journal:  Drug Deliv       Date:  2018-11       Impact factor: 6.419
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.